← All companies

COGT

Cogent Biosciences, Inc.

COGT Nasdaq Pharmaceutical Preparations EDGAR ↗

$38.86

-2.50 -6.04%

Key statistics

from XBRL data in SEC filings

Market cap

$6.64B

Revenue (TTM)

$7.87M

Net income (TTM)

-$354M

EPS (TTM)

$-2.17

P/E ratio

—

Dividend yield

—

Free cash flow

-$266M

Cash

$241M

Total assets

$903M

Gross margin

—

52-week range

$10.38 – $43.73

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Shareholder vote results Jun 11, 2026 10-Q Quarter ended 2026-03-31 May 5, 2026 8-K Results of operations (earnings release) May 5, 2026 10-K Fiscal year ended 2025-12-31 Feb 17, 2026 8-K Results of operations (earnings release) Feb 17, 2026 8-K Other events Dec 8, 2025 8-K Entered a material agreement; Took on a direct financial obligation Nov 18, 2025 8-K Entered a material agreement; Other events Nov 13, 2025 8-K Regulation FD disclosure; Other events Nov 10, 2025 10-Q Quarter ended 2025-09-30 Nov 7, 2025 8-K Results of operations (earnings release) Nov 3, 2025 8-K Entered a material agreement; Took on a direct financial obligation Sep 11, 2025 10-Q Quarter ended 2025-06-30 Aug 5, 2025 8-K Results of operations (earnings release) Aug 5, 2025 8-K Entered a material agreement; Results of operations (earnings release) Jul 10, 2025 8-K Other events Jul 7, 2025 8-K Entered a material agreement; Took on a direct financial obligation; Regulation FD disclosure Jun 11, 2025 8-K Amended charter or bylaws; Shareholder vote results; Regulation FD disclosure Jun 5, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release) May 6, 2025 10-K Fiscal year ended 2024-12-31 Feb 25, 2025 8-K Results of operations (earnings release) Feb 25, 2025 8-K Other events Dec 9, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Other events Sep 3, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Results of operations (earnings release) Aug 6, 2024 8-K Other events Jun 27, 2024 8-K Amended charter or bylaws; Shareholder vote results Jun 5, 2024 10-Q Quarter ended 2024-03-31 May 7, 2024 8-K Results of operations (earnings release) May 7, 2024 8-K Unregistered sale of equity; Amended charter or bylaws Mar 22, 2024 10-K Fiscal year ended 2023-12-31 Feb 26, 2024 8-K Results of operations (earnings release) Feb 26, 2024 8-K Entered a material agreement; Unregistered sale of equity; Amended charter or bylaws; Regulation FD disclosure Feb 14, 2024 8-K Other events Dec 11, 2023 10-Q Quarter ended 2023-09-30 Nov 7, 2023 8-K Results of operations (earnings release) Nov 2, 2023 10-Q Quarter ended 2023-06-30 Aug 8, 2023